Adj. EBITDA for group of USD 29m (ARCe: USD 33m, Cons.: USD 29.3m)Ad. EBITDA excluding Food Ingredients was USD7.7 (ARCe USD11.8m)Key deviation was Human Health which came in lower at USD8.9m EBITDA (ARCe: USD11.8, Cons: USD11.4)Human Health (Superba) achieved sales of USD25.4m (ARCe USD25.3m)AKBM notes that it had lower margins on new product categories (PL+, Algae oil, QHP and higher overhead costs)Houston plant has produced at normalized level during Q2 and is on track to reach production for ....
